11.3.2019

Responsible Influencer Marketing is Your Calling Card

Marketing is constantly changing shape and expanding to new platforms. For example, traditional print marketing is increasingly being replaced by commercial cooperation with carefully chosen social media influencers. Influencer marketing is usually much better at reaching the desired target group. However, it is important to remember that newer forms of marketing are still subject to the Finnish Consumer Protection Act’s provisions concerning good marketing practices and improper marketing.

 

‘We’re Just Sending Review Products–That’s Not Marketing, Is It?’

Sending products to an Instragram influencer, YouTuber or blogger in the hopes that they will mention the product on their channel counts as marketing, even if no commercial cooperation has actually been agreed—the requirements that marketing be identifiable still apply.

From the perspective of the Consumer Protection Act, all activities that seek to influence consumers commercially are essentially marketing.  Influence can be direct or indirect, but it can never be hidden.

Consumers Have the Right to Know When Someone Is Attempting to Influence them Commercially

The Consumer Protection Act’s requirement for the identification of marketing has two dimensions. First, marketing must clearly show its commercial purpose and on whose behalf it is. The purpose of the identification requirement is that consumers can see when and on whose behalf someone is attempting to influence them commercially. This requirement applies to all marketing regardless of method.

The identification of marketing has given rise to a great deal of debate both in Finland and abroad. The Council of Ethics in Advertising of the Finland Chamber of Commerce has issued numerous statements on the identification of marketing on social media. Competition and Markets Authority (CMA) in Great Britain has gone so far as to publish a ‘naming and shaming’ list of influencers who do not mark commercial cooperation clearly enough, in other words, who engage in hidden advertising.

Clear and Visible at First Glance

One statement issued last year concerned the identification of an advertisement on the Instagram Story feature. The Story feature allows influencers to post pictures, text and short videos to Instagram that are visible for 24 hours. The Story post in question was marked as commercial cooperation by putting text in the upper corner of the post. However, this text was partially covered by the influencer’s username and profile picture. The white font of the text also partially blended in with the background, which hindered identification.

The conclusion was that the advertisement published using the Story feature was not clearly identifiable as advertising to the average consumer. There are two points worth highlighting from the reasoning:

The identification of advertising is always subject to an overall assessment. For example, using the Instagram Story feature emphasises the requirement for clarity, because the feature uses quickly changing pictures and videos. The fact that a post is an advertisement and the name of the advertiser must be clearly marked on advertisements published using the feature in such a way that they can be seen at a glance.

Identification Requirement Emphasised on Social Media

The expansion of the field of advertising can also be seen in a decision concerning a YouTube video concerning plastic surgery. According to the advertiser, the video was not made for the purposes of advertising, rather the YouTuber in question approached the advertiser to make the video. The existence of cooperation had been stated in the publication information, which could be read by clicking on ‘Show more’. This was found to be hidden advertising.

The decision also separately stated that it did not matter who approached who to make the video. The Council of Ethics in Advertising noted that the identification of advertising and the mentioning of the advertiser is emphasised in social media posts that contain a great deal of editorial material. A large number of the YouTuber’s viewers were minors, which also made the advertising inappropriate. The advertiser was issued a warning.

Companies Bear Liability and Brand Risk

The above decisions show that advertisers have to know their environment. It is essential to know what platforms are being used for advertising and what the influencer’s target audience is like. For example, in the plastic surgery case, a large number of the viewers were minors, which meant that the marketing should have taken particular care not only with respect to identification, but also to complying with good practices and being suitable for minors.

It is vital for companies to remember that they ultimately bear the legal liability and brand risk for marketing through influencers. A company can free itself from liability if it can prove that it gave the influencer sufficient instructions on how to carry out the marketing. This means that it is particularly important to draft an agreement on influencer cooperation that makes the obligations concerning the identification of advertising sufficiently clear.

Responsible marketing can also be a calling card. Consumers are increasingly aware and see hidden marketing as unprofessional. Consumers remember brands that engage in good and transparent marketing as responsible and positive actors.

Latest references

We are acting as the lead counsel to Fortum in a cross-border transaction in which Fortum is selling its recycling and waste business. The business is sold to thematic impact investing firm Summa Equity through its portfolio company NG Group. The debt-free purchase price is approximately EUR 800 million. The transaction is subject to authority approval and customary closing conditions. Fortum’s recycling and waste business to be sold comprises municipal and industrial waste management and end-to-end plastics, metals, ash, slag and hazardous waste treatment and recycling services. These businesses are located in Finland, Sweden, Denmark and Norway and currently employ approximately 900 employees.
Case published 18.7.2024
We successfully represented Onses Finland Oy before the Finnish Market Court in an exceptionally extensive dispute concerning alleged trademark infringement and unfair business practice. Our client, Onses Finland Oy, is a Finnish sports drink company and the owner of the sports drink brand ONSE. In the spring of 2023, the Polish beverage company OSHEE Polska Sp. z o.o. filed legal action against our client, alleging that the ONSE trademarks and product packaging infringed the OSHEE trademarks. The plaintiff’s secondary claims concerned alleged slavish imitation of the OSHEE sports drink packaging and exploitation of the reputation of the plaintiff. The plaintiff based its suit on registered trademarks as well as allegedly established and reputed figurative and three-dimensional trademarks. The Market Court rejected all of the plaintiff’s claims. The Market Court held that the marks invoked in the suit were neither established nor marks with a reputation in Finland. As regards the registered trademarks, the Market Court found that there was no likelihood of confusion between the OSHEE and ONSE trademarks. As to the secondary claims, the Market Court held that the sports drink packaging used by the plaintiff was a normal beverage bottle, the design of which was partly determined by functional factors. The Market Court also found that there were several blue sports drinks available on the market and that the plaintiff’s product was not the first blue sports drink on the market. The plaintiff failed to show that its product packaging was original or well-known to the average consumer at the time of the launch of our client’s ONSE sports drink product, and the Market Court thus rejected the claims on slavish imitation and exploitation of reputation. The Market Court ordered the plaintiff to pay all of our client’s legal costs with statutory interest. The judgment (MAO:280/2024) is not final.
Case published 11.6.2024
We acted as the legal and ESG advisor to Mérieux Equity Partners on the acquisition of a majority stake in Labquality through a leveraged buyout by its buyout fund, Mérieux Participations 4. Existing shareholders of Labquality, including Cor Group and the management, will reinvest a portion of their proceeds into the company in connection with the transaction. Headquartered in Helsinki, Finland, Labquality is a Nordic player specialized in EQA, CRO activities and regulatory affairs, with a strong local presence in Central and Eastern Europe. The company provides a comprehensive array of services for the healthcare, medical technology, and pharmaceutical industries. The company, employing over 120 professionals and supported by a network of more than 150 external experts and consultants across its offices in Finland, Germany, and Poland, serves a diverse clientele of over 8,000 customers, including major pharmaceutical companies in over 60 countries. Mérieux Equity Partners (MxEP) is an AMF-accredited management company dedicated to equity investments in the Healthcare and Nutrition sectors. MxEP actively supports entrepreneurs and companies with differentiated products and services, giving them privileged access to its sector expertise and international network. The transaction will enable Labquality to pursue its buy & build strategy in Europe to accelerate its CRO activities while continuing strong and recurring growth in the EQA segment. Labquality will benefit from MxEP’s sector expertise and financial resources to achieve its ambition of becoming a leading European CRO and EQA platform, with fully integrated regulatory consulting capabilities to serve major customers across Europe.
Case published 4.12.2023
We advised Voisin Consulting Life Sciences (VCLS) on the acquisition of MedEngine, a leading medical science agency in the Nordics. MedEngine is a digitally minded, premium service provider for the pharmaceutical industry, built upon extensive academic expertise and years of experience in the industry. Founded in 2014, MedEngine has a strong presence across the Nordic countries with offices in Helsinki (Finland), Copenhagen (Denmark), and Stockholm (Sweden). Founded in 1997, VCLS provides end-to-end HealthTech solutions to support biotechnology, pharmaceutical and MedTech manufacturers throughout their product development. With offices in the US, France, UK, Switzerland, Denmark, Madagascar, India, and China, VCLS serves a broad range of developers and investors in HealthTech.
Case published 7.11.2023